12-hour Versus 24-hour Postpartum Magnesium Sulphate for Preeclamptic Patients

• Status: Not yet recruiting
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the use of magnesium sulfate for 12 hours versus 24 hours in postpartum women with pre-eclampsia with severe features , to ensure maximum efficacy of anticonvulsant action that can be achieved with least exposure to Mgso4 side effects.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Patients who have pre-eclampsia with severe features as defined by American College of Obstetricians and Gynecologists guidelines 2019(defined in methodology)

• Singleton pregnancy.

• who accept to participate the study.

Exclusion Criteria:

• Patients with eclampsia

• Epilepsy

• Central Nervous System disorder

• Chronic kidney disease

• Seizures due to metabolic disturbances, space occupying lesions or intra cerebral infections

• Cardiac patients

• Hypersensitivity to Mgso4